Biofidelity in the News

Biofidelity raises further $23m as it moves towards launch of ASPYRE-Lung diagnostic product

10 February 2022
Open external article
10 February 2022

Morrisville firm with 'game-changing' cancer diagnostics plots growth after $23M haul

07 February 2022
Open external article
07 February 2022

Biofidelity attracts $23M series A investment to launch lung cancer test

02 February 2022
Open external article
02 February 2022

Biofidelity set to trigger diagnostics revolution in US

13 January 2022
Open external article
13 January 2022

Biofidelity Prepares to Launch Lung Cancer Mutation Detection Assay

11 January 2022
Open article
11 January 2022

Biomarker Testing Is Not Keeping Up With Drug Innovations

09 December 2021
Open article
09 December 2021

Legislative victories fuel advocates for coverage of biomarker testing

05 November 2021
Open article
05 November 2021

Transforming cancer treatment with precision medicine

31 October 2021
Open article
31 October 2021

New California Law Increases Access to Biomarker Testing for Late-Stage Cancer Patients

25 October 2021
Open article
25 October 2021

California Bill Prohibiting Prior Authorizations for Cancer Biomarker Testing Becomes Law

13 October 2021
Open external article
13 October 2021

Breaking Down Barriers: Improving Access to Comprehensive Biomarker Testing for Cancer Patients

24 September 2021
Open article
24 September 2021

The Precision Medicine Revolution

01 November 2020
Open external article
01 November 2020